Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
19.50
-0.04 (-0.20%)
Mar 20, 2026, 4:00 PM EDT - Market closed
Amphastar Pharmaceuticals Stock Forecast
Stock Price Forecast
The 7 analysts that cover Amphastar Pharmaceuticals stock have a consensus rating of "Buy" and an average price target of $30.29, which forecasts a 55.33% increase in the stock price over the next year. The lowest target is $25 and the highest is $35.
Price Target: $30.29 (+55.33%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Amphastar Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 1 | 1 | 2 | 2 |
| Hold | 3 | 3 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $34 → $30 | Buy | Maintains | $34 → $30 | +53.85% | Feb 27, 2026 |
| Needham | Needham | Strong Buy Maintains $34 → $30 | Strong Buy | Maintains | $34 → $30 | +53.85% | Feb 27, 2026 |
| Barclays | Barclays | Hold Initiates $30 | Hold | Initiates | $30 | +53.85% | Dec 9, 2025 |
| Needham | Needham | Strong Buy Maintains $36 → $34 | Strong Buy | Maintains | $36 → $34 | +74.36% | Nov 7, 2025 |
| Needham | Needham | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +84.62% | Oct 22, 2025 |
Financial Forecast
Revenue This Year
772.74M
from 719.89M
Increased by 7.34%
Revenue Next Year
809.92M
from 772.74M
Increased by 4.81%
EPS This Year
3.38
from 2.03
Increased by 66.42%
EPS Next Year
3.58
from 3.38
Increased by 6.07%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 811.9M | 860.2M | |||
| Avg | 772.7M | 809.9M | |||
| Low | 718.1M | 749.7M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 12.8% | 11.3% | |||
| Avg | 7.3% | 4.8% | |||
| Low | -0.3% | -3.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 3.94 | 4.17 | |||
| Avg | 3.38 | 3.58 | |||
| Low | 2.93 | 2.98 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 94.0% | 23.4% | |||
| Avg | 66.4% | 6.1% | |||
| Low | 44.3% | -11.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.